CHD
MCID: CRN211
MIFTS: 74

Coronary Artery Disease (CHD) malady

Categories: Genetic diseases, Cardiovascular diseases

Aliases & Classifications for Coronary Artery Disease

Aliases & Descriptions for Coronary Artery Disease:

Name: Coronary Artery Disease 54 38 12 13 52 41 42 14 69
Coronary Heart Disease 12 29 52 69
Coronary Artery Anomaly 38 12 14
Coronary Artery Abnormality [ambiguous] 12 29
Coronary Arteriosclerosis 12 69
Myocardial Ischemia 42 69
Coronary Disease 12 42
Chd 12 45
Coronary Artery Disease, Susceptibility to 13
Congenital Anomaly of Coronary Artery 12
Coronary Artery Anomaly, Congenital 12
Coronary Artery Abnormality 12
Coronary Artery Anomaly Nos 12
Coronary Heart Disease 1 29
Coronary Syndrome 14

Classifications:



Summaries for Coronary Artery Disease

MedlinePlus : 41 coronary artery disease (cad) is the most common type of heart disease. it is the leading cause of death in the united states in both men and women. cad happens when the arteries that supply blood to heart muscle become hardened and narrowed. this is due to the buildup of cholesterol and other material, called plaque, on their inner walls. this buildup is called atherosclerosis. as it grows, less blood can flow through the arteries. as a result, the heart muscle can't get the blood or oxygen it needs. this can lead to chest pain (angina) or a heart attack. most heart attacks happen when a blood clot suddenly cuts off the hearts' blood supply, causing permanent heart damage. over time, cad can also weaken the heart muscle and contribute to heart failure and arrhythmias. heart failure means the heart can't pump blood well to the rest of the body. arrhythmias are changes in the normal beating rhythm of the heart. nih: national heart, lung, and blood institute

MalaCards based summary : Coronary Artery Disease, also known as coronary heart disease, is related to chronic myocardial ischemia and myocardial infarction, and has symptoms including angina pectoris, other and unspecified angina pectoris and chest pain. An important gene associated with Coronary Artery Disease is CX3CR1 (C-X3-C Motif Chemokine Receptor 1), and among its related pathways/superpathways are Metabolism of fat-soluble vitamins and Lipoprotein metabolism. The drugs Everolimus and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include heart, endothelial and monocytes, and related phenotypes are Decreased free cholesterol and Increased LDL uptake

Disease Ontology : 12 An artery disease that is characterized by plaque building up along the inner walls of the arteries of the heart resulting in a narrowing of the arteries and a reduced blood supply to the cardiac muscles.

Wikipedia : 71 Coronary artery disease (CAD), also known as ischemic heart disease (IHD), is a group of diseases that... more...

Description from OMIM: 607339

Related Diseases for Coronary Artery Disease

Diseases in the Coronary Artery Disease family:

Coronary Artery Disease, Autosomal Dominant, 2 Coronary Artery Disease, Autosomal Dominant, 1

Diseases related to Coronary Artery Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 311)
id Related Disease Score Top Affiliating Genes
1 chronic myocardial ischemia 33.7 ACE CRP HMGCR INS
2 myocardial infarction 30.7 ACE ADRB1 APOA1 APOA2 APOA5 APOB
3 lupus erythematosus 30.2 ACE CRP SELP
4 hypertriglyceridemia 30.2 APOA1 APOA2 APOB CETP LPA LPL
5 limb ischemia 29.9 ACE CRP INS NOS3 SELP
6 pericarditis 29.3 ACE APOA1 APOB CRP HMGCR INS
7 coronary artery disease, autosomal dominant, 1 12.3
8 coronary artery disease, autosomal dominant, 2 12.3
9 lrp6-related coronary artery disease susceptibility 12.0
10 mef2a-related coronary artery disease susceptibility 12.0
11 intermediate coronary syndrome 11.8
12 hyperlipidemia type 3 11.6
13 hypercholesterolemia, familial 11.5
14 abdominal obesity-metabolic syndrome 3 11.5
15 peripheral artery disease 11.4
16 heart disease 11.4
17 artery disease 11.3
18 atherosclerosis 11.3
19 cardiovascular disease risk factor ) 11.2
20 hypoalphalipoproteinemia 11.2
21 prinzmetal's variant angina 11.2
22 sitosterolemia 11.0
23 total anomalous pulmonary venous return 10.9
24 anomalous left coronary artery from the pulmonary artery 10.9
25 coronary heart disease 5 10.9
26 morbid obesity and spermatogenic failure 10.9
27 peripheral arterial occlusive disease 1 10.9
28 tangier disease 10.9
29 hyperlipidemia, familial combined 10.9
30 hyperlipidemia, combined, 2 10.9
31 hypercholesterolemia, due to ligand-defective apo b 10.9
32 brugada syndrome 7 10.9
33 endotheliitis 10.7
34 secretory diarrhea myopathy and deafness 10.4 ACE CRP SERPINE1
35 anaplastic ganglioglioma 10.4 APOA1 CRP LPA
36 craniodiaphyseal dysplasia 10.4 APOA1 APOB SERPINE1
37 villous adenoma 10.4 ACE CRP NOS3
38 median neuropathy 10.4 ACE NPPB PON1
39 glutathionuria 10.4 NOS3 SELE SERPINE1
40 malignant hyperthermia susceptibility 1 10.4 ACE APOB LPA
41 eye degenerative disease 10.4 ACE NOS3 NPPB
42 alzheimer disease 19, late onset 10.4 APOA2 APOB LPA
43 subclavian artery aneurysm 10.4 NOS3 SELP SERPINE1
44 mannosidosis, beta 10.3 APOA1 APOB CETP LPL
45 asphyxia neonatorum 10.3 ACE LPA LPL PON1
46 c1s deficiency 10.3 APOA5 INS LPL
47 lymphadenitis 10.3 ACE NOS3 NPPB
48 albinism, oculocutaneous, type v 10.3 APOA1 APOA2 APOB LPA
49 pyelonephritis 10.3 ACE CRP NOS3 NPPB
50 testicular lymphoma 10.3 ACE CRP SELE SELP

Graphical network of the top 20 diseases related to Coronary Artery Disease:



Diseases related to Coronary Artery Disease

Symptoms & Phenotypes for Coronary Artery Disease

Clinical features from OMIM:

607339

UMLS symptoms related to Coronary Artery Disease:


angina pectoris, other and unspecified angina pectoris, chest pain, edema, tremor, substernal pain, equilibration disorder

GenomeRNAi Phenotypes related to Coronary Artery Disease according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased free cholesterol GR00340-A-2 9.56 APOA1 APOA5 APOB CETP HMGCR LPA
2 Increased LDL uptake GR00340-A-1 8.8 APOA1 LPL SELP

MGI Mouse Phenotypes related to Coronary Artery Disease:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.07 SERPINE1 ACE ADRB1 APOA1 APOB CRP
2 growth/size/body region MP:0005378 9.97 ACE ADRB1 APOA2 APOB COG2 CX3CR1
3 homeostasis/metabolism MP:0005376 9.89 ADRB1 APOA1 APOA2 APOA5 APOB COG2
4 adipose tissue MP:0005375 9.8 ACE ADRB1 INS NOS3 SERPINE1 LPL
5 liver/biliary system MP:0005370 9.32 ACE APOA1 APOB HMGCR INS LPL

Drugs & Therapeutics for Coronary Artery Disease

Drugs for Coronary Artery Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 953)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
2
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
3
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
4
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 55-56-1 9552079 2713
5
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2 9005-49-6 772 46507594
6
Tirofiban Approved Phase 4,Phase 3,Phase 1 144494-65-5 60947
7
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1 79902-63-9 54454
8
Insulin Glargine Approved Phase 4,Phase 3 160337-95-1
9
Metformin Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 657-24-9 14219 4091
10
Zinc Approved Phase 4,Phase 3,Phase 2,Phase 1 7440-66-6 32051 23994
11
Amlodipine Approved Phase 4,Phase 3,Phase 2 88150-42-9 2162
12
Olmesartan Approved, Investigational Phase 4,Phase 2 144689-24-7, 144689-63-4 158781 130881
13
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 50-78-2 2244
14
Ranolazine Approved, Investigational Phase 4,Phase 2,Phase 3 142387-99-3, 95635-55-5 56959
15
Rivaroxaban Approved Phase 4,Phase 3,Phase 2 366789-02-8
16
Ticagrelor Approved Phase 4,Phase 2,Phase 3,Phase 1 274693-27-5 9871419
17
Warfarin Approved Phase 4,Phase 3 81-81-2 6691 54678486
18
Acarbose Approved, Investigational Phase 4,Phase 3 56180-94-0 441184
19
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 33069-62-4 36314
20
Rosiglitazone Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 122320-73-4 77999
21
Bivalirudin Approved, Investigational Phase 4,Phase 3,Phase 2 128270-60-0 16129704
22
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2 111025-46-8 4829
23
Ezetimibe Approved Phase 4,Phase 3,Phase 2,Phase 1 163222-33-1 150311
24
Cilostazol Approved Phase 4,Phase 3,Phase 2 73963-72-1 2754
25
Ticlopidine Approved Phase 4,Phase 2,Phase 3,Phase 1 55142-85-3 5472
26
Adenosine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-61-7 60961
27
Dipyridamole Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-32-2 3108
28
Regadenoson Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 313348-27-5 219024
29
Fluvastatin Approved Phase 4,Phase 3,Phase 2 93957-54-1 1548972
30
Metoprolol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 37350-58-6, 51384-51-1 4171
31
Coal tar Approved Phase 4,Phase 1,Phase 2 8007-45-2
32
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3 73590-58-6 4594
33
Pantoprazole Approved Phase 4,Phase 3,Phase 1 102625-70-7 4679
34
Dopamine Approved Phase 4,Phase 2,Phase 3 51-61-6, 62-31-7 681
35
Fenoldopam Approved Phase 4 67227-56-9, 67227-57-0 3341
36
Eptifibatide Approved, Investigational Phase 4,Phase 3,Phase 2 188627-80-7 123610
37
Nicorandil Approved Phase 4 65141-46-0 47528
38
Menthol Approved Phase 4,Phase 3,Phase 2,Early Phase 1 2216-51-5 16666
39
Carvedilol Approved, Investigational Phase 4,Phase 3 72956-09-3 2585
40
Ethanol Approved Phase 4,Phase 3,Phase 2,Early Phase 1 64-17-5 702
41
Esmolol Approved Phase 4,Phase 3,Phase 1,Phase 2 103598-03-4, 81147-92-4 59768
42
Nicardipine Approved Phase 4 55985-32-5 4474
43
Phenprocoumon Approved Phase 4 435-97-2 9908 54680692
44 Trapidil Approved Phase 4 15421-84-8
45
Pravastatin Approved Phase 4,Phase 3,Phase 2,Phase 1 81093-37-0 54687
46
Nitric Oxide Approved Phase 4,Phase 3,Phase 2,Phase 1 10102-43-9 145068
47
Bisoprolol Approved Phase 4,Phase 2,Phase 3,Early Phase 1 66722-44-9 2405
48
Candesartan Approved Phase 4,Phase 3 139481-59-7 2541
49
Diltiazem Approved Phase 4,Phase 3,Phase 1 42399-41-7 39186
50
Udenafil Approved, Investigational Phase 4 268203-93-6 6918523

Interventional clinical trials:

(show top 50) (show all 5538)
id Name Status NCT ID Phase
1 The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients With Coronary Artery Disease Unknown status NCT01508663 Phase 4
2 A Trial to Evaluate Efficacy of Heart-protecting Musk Pill Unknown status NCT01897805 Phase 4
3 The Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients Unknown status NCT01633359 Phase 4
4 Firebird 2 Versus Excel Sirolimus-eluting Stent in Treating Real-world Patients With Coronary Artery Disease Unknown status NCT01373632 Phase 4
5 Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease Unknown status NCT02294994 Phase 4
6 Endothelial Dysfunction in Subjects With History of Premature Coronary Artery Disease Unknown status NCT00917527 Phase 4
7 Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa) Unknown status NCT02030054 Phase 4
8 Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients Unknown status NCT02001883 Phase 4
9 Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD) Unknown status NCT01035528 Phase 4
10 Cerebral Artery Stenosis, Coronary Artery Disease and Arrhythmia Unknown status NCT00247533 Phase 4
11 Xience/Promus for Long Coronary Lesion Registry Unknown status NCT01147237 Phase 4
12 A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment Unknown status NCT01880879 Phase 4
13 Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume Unknown status NCT01382277 Phase 4
14 Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity Unknown status NCT01567774 Phase 4
15 Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT) Unknown status NCT02360956 Phase 4
16 Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease Unknown status NCT01768585 Phase 4
17 The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques Unknown status NCT01773512 Phase 4
18 Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity Unknown status NCT01490255 Phase 4
19 Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Unknown status NCT02334254 Phase 4
20 Safety and Effectiveness of the Coronary Momo Stent Unknown status NCT01535625 Phase 4
21 Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial) Unknown status NCT00858676 Phase 4
22 Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease Unknown status NCT01038050 Phase 4
23 Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function Unknown status NCT01825759 Phase 4
24 Assessment of Surface Coverage of Two Types of DES in Diabetes Mellitus and Non- Diabetes Mellitus Unknown status NCT01023919 Phase 4
25 Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI Unknown status NCT01781715 Phase 4
26 Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance Unknown status NCT00733174 Phase 4
27 Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor Unknown status NCT01869309 Phase 4
28 Ranolazine, Ethnicity and the Metabolic Syndrome Unknown status NCT01304095 Phase 4
29 Periodontal Therapy in Coronary Artery Patients Unknown status NCT01609725 Phase 4
30 Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents Unknown status NCT01268371 Phase 4
31 A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization Unknown status NCT01157455 Phase 4
32 Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears Unknown status NCT02004730 Phase 4
33 Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients Unknown status NCT00155350 Phase 4
34 Ranolazine for Improving Symptoms of Palpitations Unknown status NCT01495520 Phase 4
35 Atorvastatin Plus Ezetimibe on Coronary Plaque Progression Unknown status NCT01086020 Phase 4
36 Efficacy and Safety of Paclitaxel-eluting Balloon for Treatment of Lesions in Native Small Coronary Arteries Unknown status NCT01903902 Phase 4
37 Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent Unknown status NCT01233453 Phase 4
38 Diagnostic Performance of Noninvasive Fractional Flow Reserve From Computed Tomography Unknown status NCT01747317 Phase 4
39 The Effects of Omega 3 and Vitamin E Supplementation on the Serum Antioxidant Enzymes and Gene Expressions of PGC-1a, h TERT, FOXOs and SIRTs in CAD Patients Unknown status NCT02011906 Phase 4
40 Small Coronary Artery Treated by TAXUS Liberté Registry in Japan Unknown status NCT00955214 Phase 4
41 Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen Unknown status NCT01267734 Phase 4
42 Effect of Statins on the Radial Intima-media Thickness After Transradial Angioplasty Unknown status NCT00952770 Phase 4
43 Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease Unknown status NCT01418794 Phase 4
44 Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial Unknown status NCT01810224 Phase 4
45 Relationship Between Initial Plaque Characteristics and Stent Surface Coverage Patterns Unknown status NCT01024179 Phase 4
46 Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms Unknown status NCT01776567 Phase 4
47 Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques Unknown status NCT00916695 Phase 4
48 Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention Unknown status NCT01968577 Phase 4
49 Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress Unknown status NCT00808314 Phase 4
50 Platelet Function Assessment for Atherothrombotic Patients Unknown status NCT00513149 Phase 4

Search NIH Clinical Center for Coronary Artery Disease

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Coronary Artery Disease cell therapies at LifeMap Discovery.

Cochrane evidence based reviews: coronary artery disease

Genetic Tests for Coronary Artery Disease

Genetic tests related to Coronary Artery Disease:

id Genetic test Affiliating Genes
1 Coronary Heart Disease 1 29
2 Coronary Artery Disease 29
3 Coronary Heart Disease 29

Anatomical Context for Coronary Artery Disease

MalaCards organs/tissues related to Coronary Artery Disease:

39
Heart, Endothelial, Monocytes, Bone, Lung, Testes, Liver

Publications for Coronary Artery Disease

Articles related to Coronary Artery Disease:

(show top 50) (show all 3569)
id Title Authors Year
1
Low productivity of stress cardiac magnetic resonance imaging for screening of coronary artery disease. ( 28073992 )
2017
2
Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients. ( 27321479 )
2017
3
Mortality and extent of coronary artery disease in 2776 patients with type 1 diabetes undergoing coronary angiography: A nationwide study. ( 28084092 )
2017
4
Dysregulation of Vascular Endothelial Growth Factor Receptor-2 by Multiple miRNAs in Endothelial Colony-Forming Cells of Coronary Artery Disease. ( 28122380 )
2017
5
Meta-Analysis Comparing Coronary Artery Bypass Grafting to Drug-Eluting Stents and to Medical Therapy Alone for Left Main Coronary Artery Disease. ( 28532780 )
2017
6
Statin prescription strategies and atherogenic cholesterol goals attainment in Lebanese coronary artery disease patients. ( 28523462 )
2017
7
A molecular case-control study of association of HNF1A gene polymorphisms (rs2259816 and rs7310409) with risk of coronary artery disease in Iranian patients. ( 28222501 )
2017
8
Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease. ( 28414759 )
2017
9
Increased Neutrophil Extracellular Trap Formation in Uremia Is Associated with Chronic Inflammation and Prevalent Coronary Artery Disease. ( 28523279 )
2017
10
Lutein exerts anti-inflammatory effects in patients with coronary artery disease. ( 28527371 )
2017
11
Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study. ( 28086795 )
2017
12
Circulating Levels of LAMP2 in Coronary Artery Disease: Association with Serum Lipid Profile. ( 27923262 )
2017
13
High-density lipoprotein from subjects with coronary artery disease promotes macrophage foam cell formation: role of scavenger receptor CD36 and ERK/MAPK signaling. ( 27995417 )
2017
14
Gamma-glutamyl transferase and atrial fibrillation in patients with coronary artery disease. ( 27939920 )
2017
15
Atherosclerotic vascular diseases have really the same risk factors? Comparison between large abdominal aortic aneurysm and obstructive non-coronary arterial disease. ( 28509621 )
2017
16
PRISMA-combined Myeloperoxidase -463G/A gene polymorphism and coronary artery disease: A meta-analysis of 4744 subjects. ( 28328864 )
2017
17
Mutant DD genotype of NFKB1 gene is associated with the susceptibility and severity of coronary artery disease. ( 28088561 )
2017
18
Same Day Discharge versus Overnight Stay in the Hospital following Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ( 28068415 )
2017
19
Predictors of leptin concentration and association with cardiovascular risk in patients with coronary artery disease: results from the AtheroGene study. ( 26769430 )
2017
20
Mitochondrial DNA heteroplasmy in cardiac tissue from individuals with and without coronary artery disease. ( 28521548 )
2017
21
IL-8 -251A/T polymorphism contributes to coronary artery disease susceptibility in a Chinese population. ( 28218776 )
2017
22
A meta-analysis of three identified single nucleotide polymorphisms at 1p13.3 and 1q41 and their associations with lipid levels and coronary artery disease. ( 28088267 )
2017
23
Anxiety Level and Cardiac Autonomic Modulations in Coronary Artery Disease and Cardiac Syndrome X Patients. ( 28068419 )
2017
24
Phosphodiesterase type 5 inhibition may reduce diastolic function in women with ischemia but no obstructive coronary artery disease. ( 28528579 )
2017
25
Rapid rest/stress regadenoson ungated perfusion CMR for detection of coronary artery disease in patients with atrial fibrillation. ( 28528431 )
2017
26
Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms. ( 28530674 )
2017
27
Quality of Life in Patients with Coronary Artery Disease and Panic Disorder: A Comparative Study. ( 28042398 )
2017
28
Carotid versus coronary atherosclerosis burdens in acute compared with chronic symptomatic coronary artery disease. ( 28520469 )
2017
29
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease. ( 28267856 )
2017
30
Impact of nutritional assessment and body mass index on cardiovascular outcomes in patients with stable coronary artery disease. ( 28077227 )
2017
31
Prognostic Value of Coronary CT Angiography With Selective PET Perfusion Imaging in Coronary Artery Disease. ( 28528146 )
2017
32
Coronary artery disease detection - limitations of stress testing in left ventricular dysfunction. ( 28515848 )
2017
33
Assessing and Modifying Coronary Artery Disease Risk in Women. ( 28523440 )
2017
34
Promoter Polymorphism of Toll-Like Receptor 4 is Associated with a Decreased Risk of Coronary Artery Disease: A Case-Control Study in the Chinese Han Population. ( 28092654 )
2017
35
Serum Monokine Induced by Gamma Interferon Is Associated With Severity of Coronary Artery Disease. ( 28100872 )
2017
36
Longevity-Associated FOXO3 Genotype and its Impact on Coronary Artery Disease Mortality in Japanese, Whites, and Blacks: A Prospective Study of Three American Populations. ( 27694344 )
2017
37
The addition of vildagliptin to metformin prevents the elevation of interleukin 1A9 in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study. ( 28532406 )
2017
38
Acquired coronary artery disease in adult patients with congenital heart disease: a true or a false problem? ( 28072626 )
2017
39
Elevated levels of preI^1-high-density lipoprotein are associated with cholesterol ester transfer protein, the presence and severity of coronary artery disease. ( 28073362 )
2017
40
Survival Benefits of Invasive Versus Conservative Strategies in Heart Failure in Patients With Reduced Ejection Fraction and Coronary Artery Disease: A Meta-Analysis. ( 28087687 )
2017
41
Inter-ethnic marriages and severity of coronary artery disease: A multicenter study of Arabian Gulf States. ( 28515856 )
2017
42
Restrictive versus liberal blood transfusion in patients with coronary artery disease: a meta-analysis. ( 28067544 )
2017
43
PGC-1I+ (Peroxisome Proliferator-Activated Receptor I^ Coactivator 1-I+) Overexpression in Coronary Artery Disease Recruits NO and Hydrogen Peroxide During Flow-Mediated Dilation and Protects Against Increased Intraluminal Pressure. ( 28533333 )
2017
44
Effect of atorvastatin on serum omentin-1 in patients with coronary artery disease. ( 27749321 )
2017
45
Increased prevalence of coronary plaque in patients with psoriatic arthritis without prior diagnosis of coronary artery disease. ( 28052860 )
2017
46
Near-infrared spectroscopy-derived lipid core burden index predicts adverse cardiovascular outcome in patients with coronary artery disease during long-term follow-up. ( 28531282 )
2017
47
Serum concentrations of MCP-1 and IL-6 in combination predict the presence of coronary artery disease and mortality in subjects undergoing coronary angiography. ( 28534120 )
2017
48
The synergistic effect of vascular cell adhesion molecule-1 and coronary artery disease on brain-derived neurotrophic factor. ( 28131673 )
2017
49
Two-year outcome and risk factors for mortality in patients with coronary artery disease and renal failure: The prospective, observational CAD-REF Registry. ( 28526542 )
2017
50
A Variant in COX-2 Gene Is Associated with Left Main Coronary Artery Disease and Clinical Outcomes of Coronary Artery Bypass Grafting. ( 28194409 )
2017